UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 168

Sortiert nach

Newcastle disease virus: a promising vector for viral therapy, immune therapy, and gene therapy of cancer

Methods in molecular biology (Clifton, N.J.), 2009, Vol.542, p.565

2009

Volltextzugriff (PDF)

Activation of Natural Killer Cells by Newcastle Disease Virus Hemagglutinin-Neuraminidase

Journal of Virology, 2009-08, Vol.83 (16), p.8108-8121

2009

Volltextzugriff (PDF)

Oncolytic Newcastle disease virus as a prospective anti-cancer therapy. A biologic agent with potential to break therapy resistance

Expert opinion on biological therapy, 2015-12, Vol.15 (12), p.1757-1771

Schirrmacher, Volker

2015

Volltextzugriff (PDF)

Autologous tumor cell vaccines for post-operative active-specific immunotherapy of colorectal carcinoma: long-term patient survival and mechanism of function

Expert review of vaccines, 2014-01, Vol.13 (1), p.117-130

2014

Volltextzugriff (PDF)

Cell Surface Expression and Secretion of Heparanase Markedly Promote Tumor Angiogenesis and Metastasis

Proceedings of the National Academy of Sciences - PNAS, 2002-07, Vol.99 (15), p.10031-10036

2002

Volltextzugriff (PDF)

Complete remission of cancer in late-stage disease by radiation and transfer of allogeneic MHC-matched immune T cells: lessons from GvL studies in animals

Cancer Immunology, Immunotherapy, 2014-06, Vol.63 (6), p.535-543

Schirrmacher, Volker

2014

Volltextzugriff (PDF)

Bispecific Antibodies and Trispecific Immunocytokines for Targeting the Immune System Against Cancer: Preparing for the Future

BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy, 2013-02, Vol.27 (1), p.35-53

2013

Volltextzugriff (PDF)

Clinical trials of antitumor vaccination with an autologous tumor cell vaccine modified by virus infection: improvement of patient survival based on improved antitumor immune memory

Cancer Immunology, Immunotherapy, 2005-06, Vol.54 (6), p.587-598

Schirrmacher, Volker

2005

Volltextzugriff (PDF)

Synergy between TMZ and individualized multimodal immunotherapy to improve overall survival of IDH1 wild-type MGMT promoter-unmethylated GBM patients

Genes and immunity, 2022-12, Vol.23 (8), p.255-259

2022

Volltextzugriff (PDF)

Influence of Adjuvant Hormone Therapy and Chemotherapy on the Immune System Analysed in the Bone Marrow of Patients with Breast Cancer

Clinical cancer research, 2003-01, Vol.9 (1), p.174-180

2003

Volltextzugriff (PDF)

Randomized clinical studies of anti-tumor vaccination: state of the art in 2008

Expert review of vaccines, 2009-01, Vol.8 (1), p.51-66

2009

Volltextzugriff (PDF)

Selective gene transfer in vitro to tumor cells via recombinant Newcastle disease virus

Cancer gene therapy, 2005-03, Vol.12 (3), p.295-303

2005

Volltextzugriff (PDF)

Position paper: new insights into the immunobiology and dynamics of tumor-host interactions require adaptations of clinical studies

Expert review of anticancer therapy, 2020-08, Vol.20 (8), p.639-646

2020

Volltextzugriff (PDF)

Methods behind oncolytic virus-based DC vaccines in cancer: Toward a multiphase combined treatment strategy for Glioblastoma (GBM) patients

Methods in cell biology, 2024, Vol.183, p.51-113

2024

Volltextzugriff (PDF)

Danger signals in tumor cells: a risk factor for autoimmune disease?

Expert review of vaccines, 2010-04, Vol.9 (4), p.347-350

2010

Volltextzugriff (PDF)

Newcastle disease virus infection induces B7-1/B7-2-independent T-cell costimulatory activity in human melanoma cells

Cancer gene therapy, 2000-02, Vol.7 (2), p.316-323

2000

Volltextzugriff (PDF)

Role of Tumor Endothelium in CD4+CD25+ Regulatory T Cell Infiltration of Human Pancreatic Carcinoma

JNCI : Journal of the National Cancer Institute, 2007-08, Vol.99 (15), p.1188-1199

2007

Volltextzugriff (PDF)

Persistence of Dormant Tumor Cells in the Bone Marrow of Tumor Cell-Vaccinated Mice Correlates with Long-Term Immunological Protection

Proceedings of the National Academy of Sciences - PNAS, 1994-08, Vol.91 (16), p.7430-7434

1994

Volltextzugriff (PDF)

Recombinant Newcastle disease virus expressing human interleukin-2 serves as a potential candidate for tumor therapy

Virus research, 2008-09, Vol.136 (1), p.75-80

2008

Volltextzugriff (PDF)

Long-term survival of a breast cancer patient with extensive liver metastases upon immune and virotherapy: a case report

Immunotherapy, 2015-08, Vol.7 (8), p.855-860

2015

Volltextzugriff (PDF)

Functional and in Situ Evidence for Nitric Oxide Production Driven by CD40-CD40L Interactions in Graft-versus-Leukemia Reactivity

Clinical cancer research, 2000-05, Vol.6 (5), p.1988-1996

2000

Volltextzugriff (PDF)

Induction of Interferon-α and Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand in Human Blood Mononuclear Cells by Hemagglutinin-Neuraminidase but Not F Protein of Newcastle Disease Virus

Virology (New York, N.Y.), 2002-05, Vol.297 (1), p.19-30

2002

Volltextzugriff (PDF)

Induction of NO synthesis in macrophages by Newcastle disease virus is associated with activation of nuclear factor-κB

International immunology, 1996-04, Vol.8 (4), p.491-498

1996

Volltextzugriff (PDF)

T cell-mediated immunotherapy of metastases: state of the art in 2005

Expert opinion on biological therapy, 2005-08, Vol.5 (8), p.1051-1068

Schirrmacher, Volker

2005

Volltextzugriff (PDF)

High frequencies of functional tumor-reactive t cells in bone marrow and blood of pancreatic cancer patients

Cancer research (Chicago, Ill.), 2005-11, Vol.65 (21), p.10079-10087

2005

Volltextzugriff (PDF)

1 – 25 von 168

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect Journals

KollektionMEDLINE

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(160)
Mit Volltextzugriff
(154)

Publikationsform

Artikel
(167)
Buchkapitel
(1)

Sprache

Englisch
(168)
Japanisch
(12)

Erscheinungsjahr

n.n

Thema

Science & Technology
(122)
Animals
(118)
Life Sciences & Biomedicine
(117)
Mice
(97)
Humans
(79)
Oncology
(73)
Biological And Medical Sciences
(69)
Medical Sciences
(59)
Mice, Inbred Dba
(48)
Female
(44)
Tumors
(43)
T-Lymphocytes - Immunology
(39)
Immunology
(37)
Immunotherapy
(28)
Newcastle Disease Virus
(26)
Cell Line
(25)
Neoplasm Metastasis
(25)
Newcastle Disease Virus - Immunology
(23)
Tumor Cells, Cultured
(21)
Pharmacology. Drug Treatments
(20)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Newcastle disease virus: a promising vector for viral therapy, immune therapy, and gene therapy of cancer

Activation of Natural Killer Cells by Newcastle Disease Virus Hemagglutinin-Neuraminidase

Oncolytic Newcastle disease virus as a prospective anti-cancer therapy. A biologic agent with potential to break therapy resistance

Autologous tumor cell vaccines for post-operative active-specific immunotherapy of colorectal carcinoma: long-term patient survival and mechanism of function

Cell Surface Expression and Secretion of Heparanase Markedly Promote Tumor Angiogenesis and Metastasis

Complete remission of cancer in late-stage disease by radiation and transfer of allogeneic MHC-matched immune T cells: lessons from GvL studies in animals

Bispecific Antibodies and Trispecific Immunocytokines for Targeting the Immune System Against Cancer: Preparing for the Future

Clinical trials of antitumor vaccination with an autologous tumor cell vaccine modified by virus infection: improvement of patient survival based on improved antitumor immune memory

Synergy between TMZ and individualized multimodal immunotherapy to improve overall survival of IDH1 wild-type MGMT promoter-unmethylated GBM patients

Influence of Adjuvant Hormone Therapy and Chemotherapy on the Immune System Analysed in the Bone Marrow of Patients with Breast Cancer

Randomized clinical studies of anti-tumor vaccination: state of the art in 2008

Selective gene transfer in vitro to tumor cells via recombinant Newcastle disease virus

Position paper: new insights into the immunobiology and dynamics of tumor-host interactions require adaptations of clinical studies

Methods behind oncolytic virus-based DC vaccines in cancer: Toward a multiphase combined treatment strategy for Glioblastoma (GBM) patients

Danger signals in tumor cells: a risk factor for autoimmune disease?

Newcastle disease virus infection induces B7-1/B7-2-independent T-cell costimulatory activity in human melanoma cells

Role of Tumor Endothelium in CD4+CD25+ Regulatory T Cell Infiltration of Human Pancreatic Carcinoma

Persistence of Dormant Tumor Cells in the Bone Marrow of Tumor Cell-Vaccinated Mice Correlates with Long-Term Immunological Protection

Recombinant Newcastle disease virus expressing human interleukin-2 serves as a potential candidate for tumor therapy

Long-term survival of a breast cancer patient with extensive liver metastases upon immune and virotherapy: a case report

Functional and in Situ Evidence for Nitric Oxide Production Driven by CD40-CD40L Interactions in Graft-versus-Leukemia Reactivity

Induction of Interferon-α and Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand in Human Blood Mononuclear Cells by Hemagglutinin-Neuraminidase but Not F Protein of Newcastle Disease Virus

Induction of NO synthesis in macrophages by Newcastle disease virus is associated with activation of nuclear factor-κB

T cell-mediated immunotherapy of metastases: state of the art in 2005

High frequencies of functional tumor-reactive t cells in bone marrow and blood of pancreatic cancer patients

Aktive Filter

Suchergebnisse filtern